Home

The Alzheimer Society of Toronto is here to help

Welcome to the Alzheimer Society of Toronto!

A photo of three participants at the 2025 Walk for Alzheimer's.

Health Canada Approves Donanemab

On May 1, 2026, Health Canada approved donanemab (Kisunla™) to treat people with a clinical diagnosis of mild cognitive impairment or early-stage Alzheimer’s disease (mild dementia due to Alzheimer’s disease). This is the second disease-modifying Alzheimer’s treatment approved for use in Canada. 

The Alzheimer Society of Toronto supports Health Canada’s decision to authorize donanemab as a treatment for people diagnosed with mild cognitive impairment or early-stage Alzheimer’s disease. We respect the careful and thorough process used by Health Canada to assess the safety, efficacy and tolerability data for donanemab.

It’s important to understand that this drug is not a cure. Donanemab can slow the progression of Alzheimer’s disease, but it cannot reverse it. 

Read Frequently Asked Questions

What is donanemab?

  • Donanemab is an intravenous monoclonal antibody treatment that removes amyloid plaques (a protein often connected to Alzheimer’s disease) from the brain.
  • This drug is not a cure. It is designed to slow the progression of Alzheimer’s disease.

Who is donanemab intended for?

  • The drug is only approved to be used in people with mild cognitive impairment or mild (early-stage) Alzheimer’s disease.
  • This drug is also not supposed to be used for any other form of dementia–only for dementia related to Alzheimer’s disease.

How much does donanemab cost? Will the cost be covered by provincial health plans?

  • Health Canada allows the medication to be marketed and sold within the guidelines set out by Health Canada and the manufacturer. 
  • It is still unclear how much donanemab will cost in Canada. Donanemab is approved for clinical use in Canada, however whether the cost of the drug is covered by private or public health plans will depend on the province or territory you live in. After a drug is approved by Health Canada, it takes time to determine if or whether the drug will be covered by private and/or public drug plans.

How can I request donanemab

  • A timely diagnosis of dementia offers many benefits, including better access to treatment options and support, ability to plan for the future, and more meaningful time with family and friends. Learn more about getting a diagnosis
  • Ask your health-care provider if this drug is right for you, and for more information about donanemab assessment and testing procedures. Health-care providers can provide an accurate assessment of your symptoms to determine if you can be treated with donanemab.  

IG Wealth Management Walk for Alzheimer’s

Register and Fundraise for the Walk for Alzheimer’s!
Saturday May 30, 2026
NEW LOCATION Orchard Pavilion, Downsview Park

Returning walkers and first timers alike, it’s time to rally your team members, tie up those laces, and get ready to make a difference with family, friends, and your community. We’re excited to have you join us! 

Find Programs

Help ease the way through a difficult journey

Your generosity helps us provide needed support, information and education to people with dementia, their families and caregivers. 

Are you a Health Care Professional?

Learn how to make referrals to our First Link® program to ensure that individuals and families living with dementia receive the support and information they need.

psw taking care of a senior couple
Two people facilitating the Walk for Alzheimer's, one of whom is waving a blue pompom.

Volunteer

Volunteers are an essential part of our success as an organization. With your help and contribution, we will continue to develop vibrant communities free of stigma while fostering the inclusion of people living with dementia, their families, neighbours, coworkers, and care partners.